Provided by Tiger Trade Technology Pte. Ltd.

Corcept Therapeutics

116.93
-2.8700-2.40%
Post-market: 116.930.00000.00%16:19 EDT
Volume:638.56K
Turnover:75.30M
Market Cap:12.64B
PE:257.75
High:121.30
Open:119.25
Low:116.70
Close:119.80
52wk High:126.38
52wk Low:28.66
Shares:108.10M
Float Shares:96.44M
Volume Ratio:0.72
T/O Rate:0.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4537
EPS(LYR):0.8200
ROE:8.23%
ROA:0.47%
PB:17.91
PE(LYR):142.60

Loading ...

Movement Alert|Corcept Therapeutics Rises 15.98% in Regular Trading, Q2 Earnings Massively Beat Expectations with Raised Full-Year Guidance

Market Focus
·
Jul 30

Disc Medicine Posts Smaller-than-expected Q2 Net Loss

Reuters
·
Jul 30

Phathom Pharmaceuticals Q2 Revenue Beats on Voquezna Prescription Growth

Reuters
·
Jul 30

Corcept Therapeutics price target raised to $165 from $95 at H.C. Wainwright

TIPRANKS
·
Jul 30

Premarket Movers | CORT Surges 26% as Q2 Earnings Easily Beat Expectations and Full-Year Guidance Is Raised

Market Focus
·
Jul 30

Corcept Therapeutics Inc : Canaccord Genuity Raises Target Price to $161 from $150

THOMSON REUTERS
·
Jul 30

Corcept Therapeutics (CORT) Stock Soars 22% After Hours: Here's What You Need To Know

Benzinga Earnings
·
Jul 30

Movement Alert|Corcept Therapeutics Overnight Rise 20.02%, Q2 Earnings Massively Beat Expectations with Raised Full-Year Guidance

Market Focus
·
Jul 30

Stock Track | Corcept Therapeutics Soars 25.20% in 24 Hours as Q2 Earnings Massively Beat, Guidance Raised

Stock Track
·
Jul 30

Corcept Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 30

Stock Track | Corcept Therapeutics Soars 18.34% in After-Hours Trading After Q2 Earnings Massively Beat Estimates

Stock Track
·
Jul 30

Movement Alert|Corcept Therapeutics Rises 18.34% in After-Hours Trading, Q2 Earnings Significantly Beat Expectations

Market Focus
·
Jul 30

GUIDANCE: (CORT) Corcept Therapeutics Expects Full Year 2026 Revenue Range $1.1B - $1.2B, vs. FactSet Est of $999.5M

MT Newswires Live
·
Jul 30

Earnings Flash (CORT) Corcept Therapeutics Posts Q2 EPS $0.36, vs. FactSet Est of $0.02

MT Newswires Live
·
Jul 30

Corcept Therapeutics Q2 EPS USD 0.36

Reuters
·
Jul 30

Corcept Q2 FY26 Net Income Rises to $43 Million; Revenue Climbs 32% to $256.1 Million

Reuters
·
Jul 30

Corcept Therapeutics Q2 Revenue Estimates, Raises 2026 Outlook

Reuters
·
Jul 30

Corcept Therapeutics Q2 EPS $0.36 Beats $(0.00) Estimate, Sales $256.147M Beat $219.988M Estimate

Benzinga Earnings
·
Jul 30

Corcept Therapeutics is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Jul 30

U.S. Research ROUNDUP-Boeing, Coca-Cola, PayPal

Reuters
·
Jul 29